Related Experiment Video

Updated: Aug 21, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Obesity: the worldwide epidemic

Philip T James1

  • 1International Obesity Task Force, London, UK. jeanhjames@aol.com

Clinics in Dermatology
|October 12, 2004
PubMed

Insights

Obesity rates have doubled globally, with significant regional variations. Abdominal obesity is linked to lower birth weights and childhood stunting, even in developing nations.

Area of Science:

  • Public Health
  • Epidemiology
  • Global Health

Background:

  • Global obesity prevalence has more than doubled in the past decade.
  • Standardized body mass index (BMI) classification enables worldwide prevalence comparisons.
  • International Obesity Taskforce (IOTF) BMI cut-offs are increasingly used for children.

Purpose of the Study:

  • To analyze global obesity and overweight prevalence rates.
  • To evaluate BMI data for the Global Burden of Disease analysis.
  • To explore associations between abdominal obesity, birth weight, and early childhood stunting.

Main Methods:

  • Utilizing standardized body mass index (BMI) classification for global comparisons.
  • Applying International Obesity Taskforce (IOTF) age, sex, and BMI-specific cut-off points for children.
  • Analyzing BMI data within the Global Burden of Disease framework.

Main Results:

  • Obesity prevalence varies significantly by region, with higher rates in the Middle East, Central/Eastern Europe, and North America.
  • Obesity is increasingly associated with poverty, including in developing countries.
  • Adult abdominal obesity, linked to higher morbidity, is associated with lower birth weights and childhood stunting.

Conclusions:

  • Global obesity is a growing public health concern with diverse regional patterns.
  • Socioeconomic factors, like poverty, are increasingly intertwined with obesity.
  • Early life factors such as birth weight and childhood stunting may predict adult abdominal obesity and associated health risks.

More Related Videos

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions06:54

Methods for Presenting Real-world Objects Under Controlled Laboratory Conditions

Published on: June 21, 2019

Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...